Key players in the global oligonucleotide synthesis market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global oligonucleotide synthesis market. A few expansion strategies adopted by players operating in the global oligonucleotide Synthesis market are:
The report on the global oligonucleotide synthesis market discussed individual strategies, followed by company profiles of manufacturers of oligonucleotide synthesis. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global oligonucleotide synthesis market.
Global Oligonucleotide Synthesis Market – Segmentation
|
Product Product Type |
|
|
Applications |
|
|
End User |
|
|
Region |
|
Oligonucleotide synthesis market to reach US$ 4,511.3 Mn by 2027
Oligonucleotide synthesis market is anticipated to expand at a CAGR of 9.5% from 2019 to 2027
Oligonucleotide synthesis market is driven by increasing use of synthesized oligonucleotides in diagnostics and research applications
The synthesized oligonucleotides segment dominated the global oligonucleotide synthesis market in 2018 and the trend is projected to continue during the forecast period
Key players operating in the global Oligonucleotide Synthesis market are GE Healthcare, Thermo Fischer Scientific, Agilent Technologies, Inc., Merck KGaA, Integrated DNA, Technologies, Inc., Kaneka Eurogentec S.A
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Oligonucleotide Synthesis Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Oligonucleotide Synthesis Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter’s Five Force Analysis
5.2. Value Chain Analysis
5.3. Market Outlook
5.4. Applications of Oligonucleotides
5.5. PEST Analysis
5.6. Pipeline Analysis
6. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Oligonucleotide Synthesis Market Value Forecast, by Product Type, 2017–2027
6.2.1. Reagents & Consumables
6.2.2. Equipment
6.2.3. Synthesized oligonucleotides
6.2.3.1. DNA Oligonucleotides
6.2.3.2. RNA Oligonucleotides
6.2.3.3. Others
6.3. Global Oligonucleotide Synthesis Market Attractiveness, by Product Type
7. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Oligonucleotide Synthesis Market Value Forecast, by Application, 2017–2027
7.2.1. Research
7.2.1.1. Polymerase Chain Reaction
7.2.1.2. Next Generation Sequencing
7.2.1.3. Others
7.2.2. Therapeutics
7.2.2.1. Antisense Oligonucleotides
7.2.2.2. Nucleic Acid Aptamers
7.2.3. Diagnostics
7.3. Global Oligonucleotide Synthesis Market Attractiveness, by Application
8. Global Oligonucleotide Synthesis Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Oligonucleotide Synthesis Market Value Forecast, by End-user, 2017–2027
8.2.1. Biotechnology & Pharmaceutical Companies
8.2.2. Research Institutes
8.2.3. Diagnostic Laboratories
9. Global Oligonucleotide Synthesis Market Attractiveness, by End-user
10. Global Oligonucleotide Synthesis Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Oligonucleotide Synthesis Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. North America Oligonucleotide Synthesis Market Attractiveness, by Region
11. North America Oligonucleotide Synthesis Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
11.2.1. Reagents & Consumables
11.2.2. Equipment
11.2.3. Synthesized oligonucleotides
11.2.3.1. DNA Oligonucleotides
11.2.3.2. RNA Oligonucleotides
11.2.3.3. Others
11.3. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Research
11.3.1.1. Polymerase Chain Reaction
11.3.1.2. Next Generation Sequencing
11.3.1.3. Others
11.3.2. Therapeutics
11.3.2.1. Antisense Oligonucleotides
11.3.2.2. Nucleic Acid Aptamers
11.3.3. Diagnostics
11.4. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027
11.4.1. Biotechnology & Pharmaceutical Companies
11.4.2. Research Institutes
11.4.3. Diagnostic Laboratories
11.5. North America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country, 2017–2027
11.5.1. U.S.
11.5.2. Canada
11.6. North America Oligonucleotide Synthesis Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-users
11.6.4. By Country
12. Europe Oligonucleotide Synthesis Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
12.2.1. Reagents & Consumables
12.2.2. Equipment
12.2.3. Synthesized oligonucleotides
12.2.3.1. DNA Oligonucleotides
12.2.3.2. RNA Oligonucleotides
12.2.3.3. Others
12.3. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Research
12.3.1.1. Polymerase Chain Reaction
12.3.1.2. Next Generation Sequencing
12.3.1.3. Others
12.3.2. Therapeutics
12.3.2.1. Antisense Oligonucleotides
12.3.2.2. Nucleic Acid Aptamers
12.3.3. Diagnostics
12.4. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027
12.4.1. Biotechnology & Pharmaceutical Companies
12.4.2. Research Institutes
12.4.3. Diagnostic Laboratories
12.5. Europe Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. Germany
12.5.2. U.K.
12.5.3. France
12.5.4. Spain
12.5.5. Italy
12.5.6. Rest of Europe
12.6. Europe Oligonucleotide Synthesis Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-users
12.6.4. By Country/Sub-region
13. Asia Pacific Oligonucleotide Synthesis Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
13.2.1. Reagents & Consumables
13.2.2. Equipment
13.2.3. Synthesized oligonucleotides
13.2.3.1. DNA Oligonucleotides
13.2.3.2. RNA Oligonucleotides
13.2.3.3. Others
13.3. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Research
13.3.1.1. Polymerase Chain Reaction
13.3.1.2. Next Generation Sequencing
13.3.1.3. Others
13.3.2. Therapeutics
13.3.2.1. Antisense Oligonucleotides
13.3.2.2. Nucleic Acid Aptamers
13.3.3. Diagnostics
13.4. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027
13.4.1. Biotechnology & Pharmaceutical Companies
13.4.2. Research Institutes
13.4.3. Diagnostic Laboratories
13.5. Asia Pacific Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. China
13.5.2. Japan
13.5.3. India
13.5.4. Australia & New Zealand
13.5.5. Rest of Asia Pacific
13.6. Asia Pacific Oligonucleotide Synthesis Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-users
13.6.4. By Country/Sub-region
14. Latin America Oligonucleotide Synthesis Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
14.2.1. Reagents & Consumables
14.2.2. Equipment
14.2.3. Synthesized oligonucleotides
14.2.3.1. DNA Oligonucleotides
14.2.3.2. RNA Oligonucleotides
14.2.3.3. Others
14.3. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027
14.3.1. Research
14.3.1.1. Polymerase Chain Reaction
14.3.1.2. Next Generation Sequencing
14.3.1.3. Others
14.3.2. Therapeutics
14.3.2.1. Antisense Oligonucleotides
14.3.2.2. Nucleic Acid Aptamers
14.3.3. Diagnostics
14.4. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027
14.4.1. Biotechnology & Pharmaceutical Companies
14.4.2. Research Institutes
14.4.3. Diagnostic Laboratories
14.5. Latin America Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. Brazil
14.5.2. Mexico
14.5.3. Rest of Latin America Latin America
14.6. Latin America Oligonucleotide Synthesis Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-users
14.6.4. By Country/Sub-region
15. Middle East & Africa Oligonucleotide Synthesis Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
15.2.1. Reagents & Consumables
15.2.2. Equipment
15.2.3. Synthesized oligonucleotides
15.2.3.1. DNA Oligonucleotides
15.2.3.2. RNA Oligonucleotides
15.2.3.3. Others
15.3. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Application, 2017–2027
15.3.1. Research
15.3.1.1. Polymerase Chain Reaction
15.3.1.2. Next Generation Sequencing
15.3.1.3. Others
15.3.2. Therapeutics
15.3.2.1. Antisense Oligonucleotides
15.3.2.2. Nucleic Acid Aptamers
15.3.3. Diagnostics
15.4. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by End-user, 2017–2027
15.4.1. Biotechnology & Pharmaceutical Companies
15.4.2. Research Institutes
15.4.3. Diagnostic Laboratories
15.5. Middle East & Africa Oligonucleotide Synthesis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. Rest of Middle East & Africa
15.6. Middle East & Africa Oligonucleotide Synthesis Market Attractiveness Analysis
15.6.1. By Product Type
15.6.2. By Application
15.6.3. By End-users
15.6.4. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by Tier and Size of companies)
16.2. Market Share / Position Analysis, by Company, 2018
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1. GE Healthcare
16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.1.2. Financial Overview
16.4.1.3. Product Portfolio
16.4.1.4. SWOT Analysis
16.4.1.5. Strategic Overview
16.4.2. Thermo Fisher Scientific
16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.2.2. Financial Overview
16.4.2.3. Product Portfolio
16.4.2.4. SWOT Analysis
16.4.2.5. Strategic Overview
16.4.3. Agilent Technologies, Inc.
16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.3.2. Financial Overview
16.4.3.3. Product Portfolio
16.4.3.4. SWOT Analysis
16.4.3.5. Strategic Overview
16.4.4. Merck KGaA
16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.4.2. Financial Overview
16.4.4.3. Product Portfolio
16.4.4.4. SWOT Analysis
16.4.4.5. Strategic Overview
16.4.5. Integrated DNA Technologies, Inc.
16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.5.2. Financial Overview
16.4.5.3. Product Portfolio
16.4.5.4. SWOT Analysis
16.4.5.5. Strategic Overview
16.4.6. Kaneka Eurogentec S.A. (Kaneka Corporation)
16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.6.2. Financial Overview
16.4.6.3. Product Portfolio
16.4.6.4. SWOT Analysis
16.4.6.5. Strategic Overview
16.4.7. TriLink BioTechnologies,LLC (Maravai Life Sciences)
16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.7.2. Financial Overview
16.4.7.3. Product Portfolio
16.4.7.4. SWOT Analysis
16.4.7.5. Strategic Overview
16.4.8. BioAutomation
16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.8.2. Financial Overview
16.4.8.3. Product Portfolio
16.4.8.4. SWOT Analysis
16.4.8.5. Strategic Overview
16.4.9. ATDBio Ltd.
16.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.9.2. Financial Overview
16.4.9.3. Product Portfolio
16.4.9.4. SWOT Analysis
16.4.9.5. Strategic Overview
16.4.10. Gene Design, Inc.
16.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.10.2. Financial Overview
16.4.10.3. Product Portfolio
16.4.10.4. SWOT Analysis
16.4.10.5. Strategic Overview
16.4.11. Eurofins Genomics
16.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.4.11.2. Financial Overview
16.4.11.3. Product Portfolio
16.4.11.4. SWOT Analysis
16.4.11.5. Strategic Overview
List of Tables
Table 1 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 2 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 3 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 4 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 5 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 6 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 7 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 8 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 9 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 10 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 11 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 12 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 13 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 14 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 17 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 18 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 19 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 20 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 21 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 22 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 24 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 25 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 26 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 27 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 28 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 29 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 31 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 32 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 34 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 35 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 36 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 38 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015–2025
Table 39 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 40 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015–2025
Table 41 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015–2025
Table 42 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015–2025
List of Figures
Figure 1 Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, 2017–2027
Figure 2 Global oligonucleotide Synthesis Market Value Share, by Product Type (2018)
Figure 3 Global oligonucleotide Synthesis Market Value Share, by Application (2018)
Figure 4 Global oligonucleotide Synthesis Market Value Share, by End User (2018)
Figure 5 Global oligonucleotide Synthesis Market Value Share, by Region (2018)
Figure 6 Global Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 7 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents & Consumables, 2017–2027
Figure 8 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equipment, 2017–2027
Figure 9 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthesized Oligonucleotides, 2017–2027
Figure 10 Global Oligonucleotide Synthesis Market Attractiveness, by Product Type
Figure 11 Global Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 12 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research, 2017–2027
Figure 13 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2017–2027
Figure 14 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2017–2027
Figure 15 Global Oligonucleotide Synthesis Market Attractiveness, by Application
Figure 16 Global Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 17 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2017–2027
Figure 18 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Institutes, 2017–2027
Figure 19 Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2017–2027
Figure 20 Global Oligonucleotide Synthesis Market Attractiveness, by End-user
Figure 21 Global Oligonucleotide Synthesis Market Value Share, by Region, 2017 and 2025
Figure 22 Global Oligonucleotide Synthesis Market Attractiveness, by Region, 2019–2027
Figure 23 North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 24 North America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 25 North America Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027
Figure 26 North America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 27 North America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027
Figure 28 North America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 29 North America Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027
Figure 30 North America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 31 North America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027
Figure 32 Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 33 Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 34 Europe Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027
Figure 35 Europe Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 36 Europe Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027
Figure 37 Europe Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 38 Europe Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027
Figure 39 Europe Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 40 Europe Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027
Figure 41 Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 42 Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 43 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027
Figure 44 Asia Pacific Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 45 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027
Figure 46 Asia Pacific Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 47 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027
Figure 48 Asia Pacific Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 49 Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027
Figure 50 Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 51 Latin America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 52 Latin America Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027
Figure 53 Latin America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 54 Latin America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027
Figure 55 Latin America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 56 Latin America Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027
Figure 57 Latin America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 58 Latin America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027
Figure 59 Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 60 Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
Figure 61 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Country, 2019–2027
Figure 62 Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
Figure 63 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2019–2027
Figure 64 Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
Figure 65 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Application, 2019–2027
Figure 66 Middle East & Africa Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
Figure 67 Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by End-user, 2019–2027
Figure 68 Global Oligonucleotide Synthesis Market Share, by Company, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Oligonucleotide Synthesis Market Insights, 2019-2027
